Galvanize Therapeutics Reports New Immune Activity Data
Redwood City, California, August 20, 2026 Galvanize Therapeutics, Inc. has announced new peer-reviewed evidence suggesting that its Aliya® pulsed...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Redwood City, California, August 20, 2026 Galvanize Therapeutics, Inc. has announced new peer-reviewed evidence suggesting that its Aliya® pulsed...
Toronto, Canada and Dallas, Texas, August 13, 2026 Perimeter Medical Imaging AI Inc. has announced that Intermountain Health has...
Caesarea, Israel, August 13, 2026 IceCure Medical Ltd., a developer of minimally invasive cryoablation technology for tumor treatment, has...
BENGALURU, Karnataka, India, July 29, 2026 Biocon Limited has announced that its Canadian subsidiary has received Health Canada Notice...
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
ARC-SUR-TILLE, France, July 6, 2026 Movmedix, the French orthopedic medical technology company behind the globally recognized LARS® synthetic ligament...
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSenseâ„¢ cryoablation system in...
LOS ANGELES, April 2026 Adagio Medical announced positive pivotal clinical results for its vCLAS® Ventricular Ablation System, highlighting a...
CAESAREA, Israel, March 25, 2026 IceCure Medical has reported positive five-year top-line results from its ICESECRET clinical trial, demonstrating...
LAGUNA HILLS, Calif., March 19, 2026 Adagio Medical Holdings, Inc. announced successful outcomes from Expanded Access Program (EAP) cases...
